Recs

1

Health Care's Worst Stocks 2011: Dendreon

By David Williamson | More Articles
December 23, 2011 | Comments (0)

The following video is part of our "Motley Fool Conversations" series, in which, David Williamson, health-care editor and analyst, and Austin Smith, consumer-goods editor and analyst, discuss topics around the investing world.

In today's edition, David and Austin take a look at the worst health-care performers of 2012, focusing on the worst performer of the year, Dendreon. This video reflects back on the year that was but also takes a look at what Dendreon needs to do to be successful in 2012 and the threats on the company's horizon.

Looking for our prediction for 2012? Check out The Motley Fool's brand new report, "The Motley Fool's Top Stock for 2012." It highlights a company that is revolutionizing commerce in Latin America. You can get instant access to the name of this company by clicking here -- it's free.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Austin Smith owns no shares of the companies listed above. David Williamson owns shares of Dendreon and Johnson & Johnson. The Motley Fool owns shares of Devon Energy and Dendreon. Motley Fool newsletter services have recommended buying shares of Vertex Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 1748357, ~/Articles/ArticleHandler.aspx, 5/27/2012 1:34:39 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:00 PM
DNDN $7.11 Down -0.11 -1.52%
Dendreon Corp CAPS Rating: **
SGEN $20.57 Down -0.08 -0.39%
Seattle Genetics,… CAPS Rating: ***
VRTX $64.85 Up +0.76 +1.19%
Vertex Pharmaceuti… CAPS Rating: ***
MDVN $87.38 Down -1.54 -1.73%
Medivation, Inc. CAPS Rating: **
GERN $1.42 Up +0.03 +2.16%
Geron Corp CAPS Rating: ***
HGSI $13.61 Down -0.01 -0.07%
Human Genome Scien… CAPS Rating: **

Advertisement